Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Pathology and Oncology Research

• Publication date

  2019-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12253-019-00738-6PMID 31471884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation

  2018cited by this paper
• A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas–Kidney Transplantation Recipients

  2018cited by this paper
• Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C

  2017cited by this paper
• MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue

  2017cited by this paper
• Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases

  2017cited by this paper
• Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation

  2017cited by this paper
• Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks

  2016cited by this paper
• Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

  2016cited by this paper
• Hepatocellular carcinoma: a review

  2016cited by this paper
• Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma

  2016influential reference
• Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study

  2016cited by this paper
• Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.

  2016cited by this paper
• Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection.

  2016cited by this paper
• MICA SNPs and the NKG2D system in virus-induced HCC

  2015cited by this paper
• DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection

  2015cited by this paper
• Expression and clinical value of the soluble major histocompatibility complex class I-related chain A molecule in the serum of patients with renal tumors.

  2015cited by this paper
• The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation

  2015cited by this paper
• Prognostic significance of serum sMICA levels in non-small cell lung cancer.

  2015cited by this paper
• NKG2D Ligands in Tumor Immunity: Two Sides of a Coin

  2015cited by this paper
• Natural History of Hepatitis C.

  2015cited by this paper
• A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population

  2014cited by this paper
• MICA polymorphism: biology and importance in cancer.

  2014cited by this paper
• Chronic hepatitis C and liver fibrosis.

  2014cited by this paper
• A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region.

  2013cited by this paper
• Hepatitis B virus‐induced hepatocellular carcinoma: functional roles of MICA variants

  2013cited by this paper
• Identification of a Functional Variant in the MICA Promoter Which Regulates MICA Expression and Increases HCV-Related Hepatocellular Carcinoma Risk

  2013cited by this paper
• Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.

  2013cited by this paper
• Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas

  2012cited by this paper
• Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy

  2012cited by this paper
• Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma

  2012cited by this paper
• Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer

  2012cited by this paper
• Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

  2012cited by this paper
• Management of hepatocellular carcinoma: An update

  2011cited by this paper
• Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma

  2011cited by this paper
• Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

  2011cited by this paper
• Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

  2009cited by this paper
• Cellular and molecular biology of HCV infection and hepatitis.

  2009cited by this paper
• Higher risk of cytomegalovirus reactivation in human immunodeficiency virus-1-infected patients homozygous for MICA5.1.

  2009cited by this paper
• NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142

  2009cited by this paper
• Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate

  2009cited by this paper
• Six Minute Walk Test to assess functional capacity in chronic liver disease patients.

  2007cited by this paper
• In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer

  2007cited by this paper
• Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

  2006cited by this paper
• Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance.

  2006cited by this paper
• Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

  2001cited by this paper
• Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma

  2000cited by this paper
• Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

  1999cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• A second lineage of mammalian major histocompatibility complex class I genes.

  1994cited by this paper
• A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

  1991cited by this paper
• The natural history of hepatitis.

  1969influential reference
• American Association for the Study of Liver Diseases

  1959cited by this paper

• Two major human phenotypes of MICA molecules and their differential activation to NK cells via NKG2D receptor

  2025cites this paper
• Association of MICA gene polymorphisms and SNP loci with susceptibility to rosacea.

  2025cites this paper
• Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages

  2025cites this paper
• Germline Genetic Associations for Hepatobiliary Cancers

  2023cites this paper
• Study of the association between a MICA gene polymorphism and cholangiocarcinoma in Egyptian patients

  2022cites this paper
• Đa hình đơn rs2596542 gen MICA ảnh hưởng đến lượng virus Epstein-barr (EBV) trong khối u vòm họng thể không biệt hóa

  2022cites this paper
• Von Hippel-Lindau gene single nucleotide polymorphism (rs1642742) may be related to the occurrence and metastasis of HBV-related hepatocellular carcinoma

  2021cites this paper
• TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence

  2021influential citation